Relationship between admission serum C-reactive protein and short term outcome following acute ischaemic stroke at a tertiary health institution in Nigeria

Nigerian Journal of Clinical Practice

Volumn 16, Issue 3, 2013, Pages 320-324

  Abubakar, S A ^a   Okubadejo, N U ^b   Ojo, O O ^b   Oladipo, O ^c   Ojini, F I ^b   Danesi, M A ^b  

^a AHMADU BELLO UNIVERSITY   (Nigeria)

^b Department of Medicine ^*  (Nigeria)

^c LAGOS UNIVERSITY TEACHING HOSPITAL   (Nigeria)

Author keywords

C reactive protein; Ischaemic stroke; Outcome

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN;

ARTICLE; BLOOD; BRAIN ISCHEMIA; CASE CONTROL STUDY; CEREBROVASCULAR ACCIDENT; CHI SQUARE DISTRIBUTION; FEMALE; HOSPITALIZATION; HUMAN; MALE; METABOLISM; MIDDLE AGED; NIGERIA; NONPARAMETRIC TEST; PROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

BIOLOGICAL MARKERS; BRAIN ISCHEMIA; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; NIGERIA; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; STROKE; TREATMENT OUTCOME;

EID: 84880072440     PISSN: 11193077     EISSN: None     Source Type: Journal    
DOI: 10.4103/1119-3077.113454     Document Type: Article

References (23)

1. Ojini FI, Danesi MA. Pattern of neurological admissions at Lagos University Teaching Hospital. Niger. J. Clin. Pract. 2003;5:38-41.
2. Ogun SA, Adelowo OO, Familoni OB, Jaiyesimi AE, Fakoya EA. Pattern of medical admission at Ogun state University Teaching Hospital: A three year review. West Afri J Med 2000;19:304-8.
3. Ogun SA, Ojini FI, Ogungbo B, Kolapo KO, Danesi MA. Stroke in south west Nigeria: A 10 year review. Stroke 2005;36:1120-2.
4. Ernst E, Koenig W. Fibrinogen and cardiovascular risk. Vasc Med 1997;2:115-25.
5. Ernst E, Hammerschmidt DE, Bagge U, Matrai A, Dormandy JA. Leucocytosis and risk of ischaemic diseases. JAMA 1987;257:2318-24.
6. Juhan-Vague I, Pyke SD, Alessi MC, Jespersen J, Haverkate F, Thompson SG. Fibrinolytic factors and risk of myocardial infarction or sudden death in patients with angina pectoris. Circulation 1996;94:2057-63.
7. Dinerman JL, Mehta JL, Saldeen TG, Emerson S, Wallin R, Davda R, et al. Increased neutrophil elastase release in unstable angina pectoris and acute myocardial infarction. J Am Cardiol 1990;15:1559-63.
8. Mathla KJ, Valtonen VV, Neminen MS, Asikainen S. Role of infection as risk factor for atherosclerosis, myocardial infarction and stroke. Clin Infect Dis 1998;26:719-34.
9. Rost NS, Wolf PA, Kase CS, Kelly-Hayes M, Silbershatz H, Massaro JM, et al. Plasma concentration of CRP and risk of ischaemic stroke and transient ischaemic attack: Framinghan study. Stroke 2001;32:2575-9.
10. Ross R. Atherosclerosis-an inflammatory disease. N Eng J Med 1999;340:115-26.
11. Anuk T, Assayag EB, Rotstein R, Fusman R, Zeltser D, Berliner S, et al. Prognostic implications of admission inflammatory profile in acute ischaemic neurologic events. Acta Neurol Scand 2002;106:196-9.
12. Di Napoli M, Papa F, Bocola V. Prognostic influence of increased C-Reactive protein and fibrinogen levels in ischaemic stroke. Stroke 2001;32:133-8.
13. Canova CR, Courtin C, Reinhart WH. C-Reactive protein in cerebrovascular events. Atherosclerosis 1999;147:49-53.
14. WHO MONICA project principal investigators. The World Health Organization MONICA project (monitoring trends and determinants in cardiovascular disease): A major collaboration. J Clin Epidemiol 1988;41:105-14.
15. Poungvarin N, Viriyavejakul A, Komontri C. Siriraj stroke score and validation study to distinguish supratentorial intracerebral haemorrhage from infarction. BMJ 1991;302:1565-7.
16. Appelros P, Terent A. Characteristics of the NIHSS results: Results from a population-based stroke cohort at baseline and after one year. Cerebrovasc Dis 2004;17:21-7.
17. Briggs DE, Felberg RA, Malkoff MD, Bratina P, Grotta JC. Should mild or moderate stroke be admitted to an intensive care unit. Stroke 2001;32:871-6.
18. Uyttenboogaart M, Stewart RE, Vroomen P, Keyser JD, Luijckx G. Optimizing cut off score for the Barthel index and Modified Rankin scale for defining outcome in stroke trials. Stroke 2005;36:1984-7.
19. Ben-Assayag E, Shenhar-Tsarfaty S, Bova I, Berliner S, Shopin L, Peretz H, et al. Triggered CRP concentration and CRP gene-717 AG polymorphism in acute stroke or TIA. Eur J Neurol 2007;14:315-20.
20. Smith CJ, Emsley HC, Gavin CM, Georgiou RF, Vail A, Barberan EM, et al. Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome. BMC Neurol 2004;4:2.
21. Rallidis LS, Vikelis M, Panagiotakos DB, Rizos I, Zolindaki MG, Kaliva K, et al. Inflammatory markers and in-hospital mortality in acute ischaemic stroke. Atherosclerosis 2006;189:193-7.
22. Audebert HJ, Rott MM, Eck T, Haberl RL. Systemic inflammatory response depends on initial stroke severity but is attenuated by successful thrombolysis. Stroke 2004;35:2128-33.
23. Kochaneck PM, Hallenbeck JM. Polymorph nuclear leucocyte and monocyte/ macrophage in pathogenesis of cerebral ischaemia and stroke. Stroke 1992;23:1367-79.